These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33627210)

  • 1. [Clinical features of children with Guillain-Barré syndrome and the significance of Brighton criteria].
    Liang JF; Sun RD; Wang RX; Luo J; Wang HD; Jiang J
    Zhongguo Dang Dai Er Ke Za Zhi; 2021 Feb; 23(2):153-157. PubMed ID: 33627210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Features and the Validation of the Brighton Criteria in Guillain-Barré Syndrome: Retrospective Analysis of 72 Hospitalized Patients in Three Years.
    Zeng Y; Liu Y; Xie Y; Liang J; Xiao Z; Lu Z
    Eur Neurol; 2019; 81(5-6):231-238. PubMed ID: 31574518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria.
    Fokke C; van den Berg B; Drenthen J; Walgaard C; van Doorn PA; Jacobs BC
    Brain; 2014 Jan; 137(Pt 1):33-43. PubMed ID: 24163275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of Guillain-Barré syndrome and validation of the Brighton criteria in Malaysia.
    Tan CY; Razali SNO; Goh KJ; Shahrizaila N
    J Peripher Nerv Syst; 2020 Sep; 25(3):256-264. PubMed ID: 32511817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of Guillain-Barré syndrome in children and validation of the Brighton criteria.
    Roodbol J; de Wit MY; van den Berg B; Kahlmann V; Drenthen J; Catsman-Berrevoets CE; Jacobs BC
    J Neurol; 2017 May; 264(5):856-861. PubMed ID: 28251358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barré Syndrome in India: population-based validation of the Brighton criteria.
    Mateen FJ; Cornblath DR; Jafari H; Shinohara RT; Khandit D; Ahuja B; Bahl S; Sutter RW
    Vaccine; 2011 Dec; 29(52):9697-701. PubMed ID: 22001121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guillain-Barré syndrome in Bangladesh: validation of Brighton criteria.
    Islam MB; Islam Z; Farzana KS; Sarker SK; Endtz HP; Mohammad QD; Jacobs BC
    J Peripher Nerv Syst; 2016 Dec; 21(4):345-351. PubMed ID: 27616152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guillain-Barre syndrome in Mexico: clinical features and validation of Brighton Collaboration Group criteria.
    López-Hernández JC; Galnares-Olalde JA; Gutiérrez A; Estrada SA; García-Grimshaw M; Vargas-Cañas ES
    Rev Neurol; 2022 Apr; 74(8):258-264. PubMed ID: 35383873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute flaccid myelitis and Guillain-Barré syndrome in children: A comparative study with evaluation of diagnostic criteria.
    Helfferich J; Roodbol J; de Wit MC; Brouwer OF; Jacobs BC;
    Eur J Neurol; 2022 Feb; 29(2):593-604. PubMed ID: 34747551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guillain-Barré syndrome in Denmark: a population-based study on epidemiology, diagnosis and clinical severity.
    Al-Hakem H; Sindrup SH; Andersen H; de la Cour CD; Lassen LL; van den Berg B; Jacobs BC; Harbo T
    J Neurol; 2019 Feb; 266(2):440-449. PubMed ID: 30536111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Features of Post-Vaccination Guillain-Barré Syndrome (GBS) in Korea.
    Park YS; Lee KJ; Kim SW; Kim KM; Suh BC
    J Korean Med Sci; 2017 Jul; 32(7):1154-1159. PubMed ID: 28581273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Brighton Collaboration case definition: Comparison in a retrospective and prospective cohort of children with Guillain-Barré syndrome.
    Korinthenberg R; Sejvar JJ
    J Peripher Nerv Syst; 2020 Dec; 25(4):344-349. PubMed ID: 32869396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guillain-Barré syndrome subtypes: A clinical electrophysiological study of 100 patients.
    Grapperon AM; Berro M; Salort-Campana E; Verschueren A; Delmont E; Attarian S
    Rev Neurol (Paris); 2019; 175(1-2):73-80. PubMed ID: 30442448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A follow-up study on Guillain-Barre syndrome and validation of Brighton criteria.
    Boostani R; Ramezanzadeh F; Saeidi M; Khodabandeh M
    Iran J Neurol; 2019 Apr; 18(2):64-69. PubMed ID: 31565202
    [No Abstract]   [Full Text] [Related]  

  • 15. Age matters: Impact of data-driven CSF protein upper reference limits in Guillain-Barré syndrome.
    Bourque PR; Brooks J; McCudden CR; Warman-Chardon J; Breiner A
    Neurol Neuroimmunol Neuroinflamm; 2019 Jul; 6(4):e576. PubMed ID: 31355312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Very-early and early neuroelectrophysiological features of childhood Guillain-Barré syndrome].
    Sun RD; Jiang J; Liu ZS
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Sept 15; 24(9):979-983. PubMed ID: 36111714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report: Incidence and prognostic value of brain MRI lesions and elevated cerebrospinal fluid protein in children with Guillain-Barré syndrome.
    Pizzo F; Di Nora A; Di Mari A; Costanza G; Testa E; Strazzieri M; Greco F; Timpanaro T; Basile A; Belfiore G; Giugno A; Rocca R; Ruggieri M; Fiumara A; Pavone P
    Front Neurol; 2022; 13():885897. PubMed ID: 36341115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic.
    Uncini A; Vallat JM; Jacobs BC
    J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1105-1110. PubMed ID: 32855289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of Guillain-Barré syndrome and use of Brighton criteria in Peruvian hospitals.
    Malaga M; Rodriguez-Calienes A; Velasquez-Rimachi V; Alva-Diaz C
    Arq Neuropsiquiatr; 2022 Jun; 80(6):601-606. PubMed ID: 35946711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barré syndrome as only manifestation of COVID-19 infection.
    d'Orsi G; Sica S; Maiorano A; Melchionda D; Lalla A; Montemurro L; Sabetta A; Goffredo R; Lecce B; Fiore JR; Santantonio T; Avolio C
    Clin Neurol Neurosurg; 2021 Aug; 207():106775. PubMed ID: 34175645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.